MedTrace Logo

Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation Versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation

NCT02695277 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 146

Last updated 2024-10-15

No results posted yet for this study

Summary

This is a prospective, randomized (2:1) multicenter trial to investigate the optimal treatment of Persistent and Longstanding Persistent AF referred for Radiofrequency (RF) ablation.The study objective is to compare the efficacy and safety of two interventional approaches, in preventing the recurrence of AF in symptomatic, drug refractory patients with persistent or longstanding persistent atrial fibrillation.

Conditions

Interventions

DEVICE

AtriCure Bipolar System

DEVICE

Standard Endocardial Ablation with Catheter

DEVICE

AtriClip® PRO LAA Exclusion System

DEVICE

Endocardial Ablation with Catheter

DEVICE

Repeated Endocardial ablation(s)

Sponsors & Collaborators

  • Cardialysis BV

    collaborator INDUSTRY

  • AtriCure, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2022-11-30
Completion
2024-09-30

Countries

  • Czechia
  • Germany
  • Netherlands
  • Poland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02695277 on ClinicalTrials.gov